John Sefton

1.7k total citations
37 papers, 1.3k citations indexed

About

John Sefton is a scholar working on Dermatology, Molecular Biology and Cell Biology. According to data from OpenAlex, John Sefton has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Dermatology, 11 papers in Molecular Biology and 11 papers in Cell Biology. Recurrent topics in John Sefton's work include Retinoids in leukemia and cellular processes (11 papers), Psoriasis: Treatment and Pathogenesis (11 papers) and Nail Diseases and Treatments (9 papers). John Sefton is often cited by papers focused on Retinoids in leukemia and cellular processes (11 papers), Psoriasis: Treatment and Pathogenesis (11 papers) and Nail Diseases and Treatments (9 papers). John Sefton collaborates with scholars based in United States, Ireland and France. John Sefton's co-authors include Deborah A. Lew‐Kaya, John R. Gibson, Nicholas J. Lowe, Gerald D. Weinstein, Madeleine Duvic, John Lue, Patricia Walker, Roshantha A.S. Chandraratna, William D. James and Mark Lebwohl and has published in prestigious journals such as The American Journal of Gastroenterology, Journal of the American Academy of Dermatology and European Journal of Medicinal Chemistry.

In The Last Decade

John Sefton

36 papers receiving 1.1k citations

Peers

Countries citing papers authored by John Sefton

Since Specialization

Citations

This map shows the geographic impact of John Sefton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Sefton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Sefton more than expected).

Fields of papers citing papers by John Sefton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Sefton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Sefton. The network helps show where John Sefton may publish in the future.

Co-authorship network of co-authors of John Sefton

This figure shows the co-authorship network connecting the top 25 collaborators of John Sefton. A scholar is included among the top collaborators of John Sefton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Sefton. John Sefton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Histological effects of tazarotene 0.1% cream vs. vehicle on photodamaged skin: a 6-month, multicentre, double-blind, randomized, vehicle-controlled study in patients with photodamaged facial skin 2004 ·British Journal of Dermatology ·(unknown), Kays H. Kaidbey, (unknown), Keith H. Loven, (unknown), David C. Wilson, (unknown), John Sefton, (unknown), Patricia S. Walker	16
2	Effects of tazarotene 0.1 % cream in the treatment of facial acnevulgaris: Pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials 2004 ·Clinical Therapeutics ·Alan R. Shalita, Diane Berson, Diane Thiboutot, William D. James, (unknown), John Sefton, Patricia Walker, John R. Gibson	34
3	Pharmacokinetics of Tazarotene Cream 0.1% After a Single Dose and After Repeat Topical Applications at Clinical or Exaggerated Application Rates in Patients with Acne Vulgaris or Photodamaged Skin 2003 ·Clinical Pharmacokinetics ·Zhi‐Ling Yu, John Sefton, Deborah A. Lew‐Kaya, Patricia S. Walker, Dale K. Yu, Diane D‐S. Tang‐Liu	8
4	Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks 2003 ·Journal of the American Academy of Dermatology ·Gerald D. Weinstein, John Koo, Gerald G. Krueger, Mark Lebwohl, Nicholas J. Lowe, Alan Menter, Deborah A. Lew‐Kaya, John Sefton, John R. Gibson, Patricia Walker	91
5	Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial. 2002 ·PubMed ·Tania J. Phillips, Alice B. Gottlieb, William D. James, Nicholas J. Lowe, Deborah A. Lew‐Kaya, John Sefton, Patricia Walker, John R. Gibson	64
6	Efficacy of 0.1% Tazarotene Cream for the Treatment of Photodamage 2002 ·Archives of Dermatology ·Tania J. Phillips, Alice B. Gottlieb, William D. James, Nicholas J. Lowe, Deborah A. Lew‐Kaya, John Sefton, Paul Walker, (unknown)	1
7	A pilot study to determine the effect of tazarotene gel 0.1% on steroid‐induced epidermal atrophy 2001 ·International Journal of Dermatology ·Kays H. Kaidbey, (unknown), John Sefton, John R. Gibson	34
8	Tazarotene Cream for the Treatment of Facial Photodamage 2001 ·Archives of Dermatology ·Sewon Kang, William D. James, Nicholas J. Lowe, J.‐P. Ortonne, Tania J. Phillips, Gerald D. Weinstein, Jag Bhawan, Deborah A. Lew‐Kaya, (unknown), John Sefton, Patricia Walker, John R. Gibson	76
9	Tazarotene plus UVB phototherapy in the treatment of psoriasis 2000 ·Journal of the American Academy of Dermatology ·John Koo, Nicholas J. Lowe, Deborah A. Lew‐Kaya, (unknown), John Lue, John Sefton, John R. Gibson	58
10	Photodamage pilot study: A double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel 2000 ·Journal of the American Academy of Dermatology ·John Sefton, (unknown), (unknown), John Lue, John R. Gibson	39
11	Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis 1998 ·Journal of the American Academy of Dermatology ·Mark Lebwohl, Debra Breneman, Bernard S. Goffe, (unknown), Mark Ling, (unknown), (unknown), R. Gary Sibbald, Leonard J. Swinyer, Gerald D. Weinstein, Deborah A. Lew‐Kaya, (unknown), John R. Gibson, John Sefton	106
12	Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis 1998 ·Journal of the American Academy of Dermatology ·Mark Lebwohl, (unknown), Jeffrey P. Callen, Stanley I. Cullen, (unknown), Carol L. Kulp‐Shorten, Nicholas J. Lowe, Tania J. Phillips, Ted Rosén, (unknown), (unknown), John Sefton, (unknown), John R. Gibson, R A Chandraratna	63
13	Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect 1997 ·Journal of the American Academy of Dermatology ·Gerald D. Weinstein, Gerald G. Krueger, Nicholas J. Lowe, Madeleine Duvic, David J. Friedman, Brian V. Jegasothy, Joseph L. Jorizzo, Edward Shmunes, Eduardo Tschen, Deborah A. Lew‐Kaya, John Lue, John Sefton, John R. Gibson, (unknown)	131
14	Response of psoriasis to a new topical retinoid, AGN 190168 1994 ·Journal of the American Academy of Dermatology ·(unknown), Roshantha A.S. Chandraratna, Deborah A. Lew‐Kaya, John Sefton, Madeleine Duvic	110
15	Double-blind comparison of naftifine cream and clotrimazole/betamethasone dipropionate cream in the treatment of tinea pedis 1992 ·Journal of the American Academy of Dermatology ·Edgar B. Smith, Debra Breneman, (unknown), Adelaide A. Hebert, Janet G. Hickman, Jennifer Maloney, Larry E. Millikan, Virginia I. Sulica, Sydney H. Dromgoole, John Sefton, Ronald E. DeGryse, (unknown)	33
16	Comparison of once- and twice-daily naftifine cream regimens with twice-daily clotrimazole in the treatment of tinea pedis 1990 ·Journal of the American Academy of Dermatology ·Edgar B. Smith, Karen Wiss, Jon M. Hanifin, Robert E. Jordon, Ronald P. Rapini, (unknown), (unknown), Larry E. Millikan, Lawrence Charles Parish, Marvin J. Rapaport, Henry H. Roenigk, Nardo Zaias, Sydney H. Dromgoole, John Sefton, Ronald E. DeGryse, (unknown)	19
17	Once‐Daily Naftifine Cream 1% in the Treatment of Tinea Cruris and Tinea Corporis 1990 ·International Journal of Dermatology ·Robert E. Jordon, Ronald P. Rapini, (unknown), H. Irving Katz, Janet G. Hickman, (unknown), Roland S. Medansky, Deborah A. Lew‐Kaya, John Sefton, Ronald E. DeGryse, (unknown)	9
18	The safety and efficacy of naftifine cream 1% in the treatment of tinea pedis 1990 ·Lawrence A. Schachner, (unknown), (unknown), Isaac Willis, John Sefton, Ronald E. DeGryse	3
19	In vitro and in vivo cutaneous penetration and antifungal activity of naftifine. 1989 ·PubMed ·Richard B. Stoughton, John Sefton, L. D. Zeleznick	6
20	Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis 1988 ·Journal of the American Academy of Dermatology ·Larry E. Millikan, Wesley K. Galen, (unknown), (unknown), (unknown), Lee T. Nesbitt, Harry L. Roth, John Sefton, Robert M. Day	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact